Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

SOME Nigerians, with a wrong intent to mock, believe that sick people, especially those living with Human Immunodeficiency Virus (HIV) in Africa, particularly Nigeria, are now an “endangered species” ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.

Salesh Jindal, senior vegetable breeder, department of vegetable science, said that CH-27 is a high-yielding hybrid, with ...